Combining components of quality of life to increase precision and evaluate trade-offs

Statistics in Medicine

Volumn 20, Issue 21, 2001, Pages 3231-3249

  Lumley, T ^a   Simes, R J ^a   Gebski, V ^a   Hudson, H M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; MEGESTROL ACETATE; METHOTREXATE; MITOXANTRONE; PLACEBO; PREDNISONE;

ACCURACY; APPETITE; ARTICLE; BREAST CANCER; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; EVALUATION; FATIGUE; HAIR LOSS; HUMAN; LINEAR SYSTEM; METHODOLOGY; MOOD; NAUSEA AND VOMITING; PAIN; PARESTHESIA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; WELLBEING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIAS (EPIDEMIOLOGY); BIOMETRY; BREAST NEOPLASMS; CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; LINEAR MODELS; MEGESTROL ACETATE; MULTIVARIATE ANALYSIS; QUALITY OF LIFE;

EID: 0035889559     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1035     Document Type: Article

References (23)

1. Lessons learned from measuring health-related quality of life of oncology
2. On the receiving end iii: Measurement of quality of life during cancer chemotherapy
3. Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: A randomised placebo-controlled trial
4. Evaluation of quality of life in patients receiving treatment for advanced breast cancer
5. Measuring the quality of life of cancer patients: A concise QL-Index for use by physicians
6. Quality of life during chemotherapy in advanced breast cancer: A randomised trial comparing single-agent mitozantrone with cmfp (cyclophosphamide, methotrexate, 5-fluorouracil, prednisone)
7. Feasible nonparametric estimation of multiargument monotone functions
8. Application of multiattribute utility theory to measure social preferences for health states
9. The 'q-tility index': A new tool for assessing health-related quality of life and utilities in clinical trials and clinical practice
10. A note on the regression analysis of censored data
11. Procedures for comparing samples with multiple endpoints
12. The analysis of multiple endpoints in clinical trials
13. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate
14. On the design and analysis of randomized clinical trials with multiple endpoints
15. Quality-of-life assessment: Can we keep it simple?
16. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection
17. Psychometric considerations in evaluating health-related quality of life measures
18. The nonexistence of interpersonal utility scales: A missing link in medical decision theory?